pharmaceutical investing EyeGate Completes Enrollment and Receives Milestone Payment for Confirmatory Phase 3 Clinical Study of EGP-437
G1 Therapeutics Reports Fourth Quarter and Full-Year 2017 Financial Results and Recent Operational Highlights
Standard Uranium Executes Letter of Intent to Option Rocas Uranium Project in Eastern Athabasca Basin
NevGold Announces Updated Open-Pit, Heap-Leach Gold Mineral Resource Including 1,186,000 ozs Indicated and 548,000 ozs Inferred At Nutmeg Mountain in Idaho
Sun Summit Strengthens Cu-Au Porphyry Potential at the JD Project, Toodoggone District: Defines an Open-Ended 8.5 km Long IP Anomaly
